Innovative diagnostic approaches: Serum protein markers in renal cell carcinoma.

被引：0
|
作者：
Davis, Laura Elizabeth
Wang, Betty
Maina, Eran Ndegwa
Campbell, Rebecca
Sindhani, Mohit
Wee, Christopher Eing
Weight, Christopher
Abbosh, Phillip
Campbell, Steven
Abouassaly, Robert
Calaway, Adam C.
Barata, Pedro C.
Bukavina, Laura
机构：
[1] Univ Hosp, Seidman Canc Ctr, Cleveland, OH USA
[2] Cleveland Clin, Glickman Urol Inst, Cleveland, OH USA
[3] Cleveland Clin, Lerner Coll Med, Cleveland, OH USA
[4] Indian Inst Technol, Delhi, India
[5] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH USA
[6] Fox Chase Canc Ctr, Philadelphia, PA USA
[7] Univ Hosp, Dept Urol, Cleveland Med Ctr, Cleveland, OH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 5_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.5_suppl.560
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
560
引用
收藏
页码：560 / 560
页数：1
相关论文
共 50 条
  • [41] Duodenal metastasis from renal cell carcinoma.
    Mateo, MAG
    Lopez, JOD
    Aguirregoitia, JD
    Fernandez, GM
    Hiriart, MC
    GarciaSanFrechoso, AE
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1996, 88 (05) : 361 - 363
  • [42] Association of inflammation and depression in renal cell carcinoma.
    Schmeusser, Benjamin
    Ali, Adil
    Patil, Dattatraya H.
    Midenberg, Eric
    Petrinec, Benjamin
    Bilen, Mehmet Asim
    Ogan, Kenneth
    Master, Viraj A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [43] Cruciferous vegetables in relation to renal cell carcinoma.
    Yuan, JM
    Gago-Dominguez, M
    Castelao, JE
    Hankin, JH
    Ross, RK
    Yu, MC
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1998, 147 (11) : S53 - S53
  • [44] Assessment of metastasectomy complications in renal cell carcinoma.
    Meyer, Christian P.
    Sun, Maxine
    de Velasco, Guillermo
    Quoc-Dien Trinh
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [45] Invasive renal pelvis transitional cell carcinoma.
    Freiha, F
    Srinivas, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 430S - 430S
  • [46] Metabolic barriers to immunotherapy in renal cell carcinoma.
    Beckermann, Katy
    Siska, Peter
    Mason, Frank
    Rathmell, Kimryn
    Rathmell, Jeffrey C.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [47] Differentiating hemangioblastoma from renal cell carcinoma.
    Shan, Y
    Rubio, A
    Stewart, J
    Powers, JM
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1998, 57 (05): : 526 - 526
  • [48] The membrane proteases ADAMS and hepsin are differentially expressed in renal cell carcinoma. Are they potential tumor markers?
    Roemer, A
    Schwettmann, L
    Jung, M
    Stephan, C
    Roigas, J
    Kristiansen, G
    Loening, SA
    Lichtinghagen, R
    Jung, K
    JOURNAL OF UROLOGY, 2004, 172 (06): : 2162 - 2166
  • [49] Prognostic and diagnostic value of serum hyaluronan in patients with pancreatic carcinoma.
    Chen, Inna
    Dehlendorff, Christian
    Johansen, Astrid Zedlitz
    Jensen, Benny Vittrup
    Kruger, Mie Barthold
    Pfeiffer, Per
    Bjerregaard, Jon Kroll
    Bojesen, Stig Egil
    Nielsen, Svend Erik
    Hollander, Niels Henrik
    Yilmaz, Mette
    Rasmussen, Louise Skau
    Johansen, Julia S.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [50] Predictive value of serum immunosuppressive acidic protein for staging renal cell carcinoma: Comparison with other tumour markers
    Masuda, H
    Kurita, Y
    Suzuki, K
    Fujita, K
    Aso, Y
    BRITISH JOURNAL OF UROLOGY, 1997, 80 (01): : 25 - 29
12345